J. Safra Sarasin Holding’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$91.8M Buy
89,972
+359
+0.4% +$367K 1.32% 15
2026
Q1
$82.4M Buy
89,613
+7,285
+9% +$7.39M 1.4% 15
2025
Q4
$88.5M Buy
82,328
+12,069
+17% +$11.5M 1.44% 16
2025
Q3
$53.6M Sell
70,259
-11,416
-14% -$8.5M 0.87% 37
2025
Q2
$63.7M Buy
81,675
+6,061
+8% +$4.71M 1.1% 27
2025
Q1
$62.5M Sell
75,614
-5,358
-7% -$4.46M 1.13% 29
2024
Q4
$62.5M Sell
80,972
-12,497
-13% -$10.3M 1.06% 29
2024
Q3
$82.8M Buy
93,469
+22,550
+32% +$20.3M 1.44% 15
2024
Q2
$64.1M Buy
+70,919
New +$56.7M 1.17% 22

Other funds holding LLY

J. Safra Sarasin Holding's LLY Position: Q2 2026 in Review

J. Safra Sarasin Holding increased its Eli Lilly (LLY) stake by 0.4% in Q2 2026, buying an estimated $367K and bringing the position to 89,972 shares worth $91.8M. The position accounts for 1.32% of the portfolio, ranked #15.

J. Safra Sarasin Holding first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • J. Safra Sarasin Holding held 89,972 shares of Eli Lilly worth $91.8M as of Q2 2026.
  • J. Safra Sarasin Holding bought 359 Eli Lilly shares in Q2 2026, an estimated $367K.
  • Eli Lilly made up 1.32% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #15 holding.
  • J. Safra Sarasin Holding first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.